Outcomes of patients undergoing percutaneous biliary drainage to reduce bilirubin for administration of chemotherapy

Journal of Vascular and Interventional Radiology

Volumn 23, Issue 1, 2012, Pages 89-95

  Thornton, Raymond H ^a   Ulrich, Robert ^b   Hsu, Meier ^a   Moskowitz, Chaya ^a   Reidy Lagunes, Diane ^a   Covey, Anne M ^a   Brody, Lynn A ^a   Robson, Piera M ^a   Sofocleous, Constantinos T ^a   Solomon, Stephen B ^a   Getrajdman, George I ^a   Brown, Karen T ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BILIRUBIN;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILE LEAKAGE; BILIARY TRACT DRAINAGE; BILIRUBIN BLOOD LEVEL; BLEEDING; CANCER CHEMOTHERAPY; CHILD; DEMOGRAPHY; FEMALE; FOLLOW UP; GALLBLADDER CANCER; HUMAN; IMAGING; INFUSION PUMP; INTERNATIONAL NORMALIZED RATIO; LIVER; MAJOR CLINICAL STUDY; MALE; MEDICAL INFORMATION; MEDICAL RECORD; METASTASIS; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS CANCER; PATIENT SELECTION; PRIORITY JOURNAL; SCHOOL CHILD; TREATMENT INDICATION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; BILIRUBIN; CHILD; CHOLANGIOCARCINOMA; DRAINAGE; FEMALE; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; PATIENT SELECTION; RETROSPECTIVE STUDIES; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 84855354043     PISSN: 10510443     EISSN: 15357732     Source Type: Journal    
DOI: 10.1016/j.jvir.2011.09.022     Document Type: Article

References (16)

1. Venook AP, Egorin MJ, Rosner GL, et al. Phase I and pharmacokinetic trial of gemcitabine in patients with hepatic or renal dysfunction: Cancer and Leukemia Group B 9565. J Clin Oncol 2000; 18:2780-2787. (Pubitemid 30463562)
2. Brown KT, Kemeny N, Berger MF, et al. Obstructive jaundice in patients receiving hepatic artery infusional chemotherapy: etiology, treatment implications, and complications after transhepatic biliary drainage. J Vasc Interv Radiol 1997; 8:229-234. (Pubitemid 27522875)
3. Satagopan JM, Ben-Porat L, Berwick M, Robson M, Kutler D, Auerbach AD. A note on competing risks in survival data analysis. Br J Cancer 2004; 91:1229-1235. (Pubitemid 39424779)
4. Fine JP, Gray RJ. A proportional hazards model for the subdistribution of a competing risk. J Am Stat Assoc 1999; 94:496-509.
5. Lausen B, Schumacher M. Maximally selected rank statistics. Biometrics 1992; 48:73-85.
6. R Development Core Team. R: a language and environment for statistical computing. Vienna: R Foundation for Statistical Computing, 2011.
7. Saad WE, Wallace MJ, Wojak JC, Kundu S, Cardella JF. Quality improvement guidelines for percutaneous transhepatic cholangiography, biliary drainage, and percutaneous cholecystostomy. J Vasc Interv Radiol 2010; 21:789-795.
8. Martin JA, Slivka A, Rabinovitz M, Carr BI, Wilson J, Silverman WB. ERCP and stent therapy for progressive jaundice in hepatocellular carcinoma: which patients benefit, which patients don't? Dig Dis Sci 1999; 44:1298-1302. (Pubitemid 29404288)
9. Eklund JW, Trifilio S, Mulcahy MF. Chemotherapy dosing in the setting of liver dysfunction. Oncology (Williston Park) 2005; 19:1057-1063. (Pubitemid 41725374)
10. Donelli MG, Zucchetti M, Munzone E, D'Incalci M, Crosignani A. Pharmacokinetics of anticancer agents in patients with impaired liver function. Eur J Cancer 1998; 34:33-46. (Pubitemid 28123378)
11. Weston BR, Ross WA, Wolff RA, et al. Rate of bilirubin regression after stenting in malignant biliary obstruction for the initiation of chemotherapy: how soon should we repeat endoscopic retrograde cholangiopancreatography? Cancer. 2008; 112:2417-2423.
12. Green RM, Flamm S. AGA technical review on the evaluation of liver chemistry tests. Gastroenterology 2002; 123:1367-1384.
13. Ballinger AB, McHugh M, Catnach SM, Alstead EM, Clark ML. Symptom relief and quality of life after stenting for malignant bile duct obstruction. Gut 1994; 35:467-470. (Pubitemid 24131241)
14. Robson PC, Heffernan N, Gonen M, et al. Prospective study of outcomes after percutaneous biliary drainage for malignant biliary obstruction. Ann Surg Oncol 2010; 17:2303-2311.
15. Jarnagin WR, Burke E, Powers C, Fong Y, Blumgart LH. Intrahepatic biliary enteric bypass provides effective palliation in selected patients with malignant obstruction at the hepatic duct confluence. Am J Surg 1998; 175:453-460. (Pubitemid 28272969)
16. Kuvshinoff BW, Armstrong JG, Fong Y, et al. Palliation of irresectable hilar cholangiocarcinoma with biliary drainage and radiotherapy. Br J Surg 1995; 82:1522-1525.